Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium

Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium

Introduction: Vaccination of hamsters with Schistosoma mansoni adjuvant-free recombinant cathepsin B1 (SmCB1) and L3 (SmCL3) have been shown to elicit highly significant (P < 0.005) protection against challenge Schistosoma haematobium that was not very superior to that achieved by the cysteine pe...

Full description

Bibliographic Details
Main Authors: Nada Abdel Aziz, Hatem Tallima, Marwa Abou El Dahab, Rashika El Ridi
Format: Article
Language:English
Published: Pasteur Institute of Iran 2019-12-01
Series:Vaccine Research
Subjects:
schistosoma haematobium
hamsters
cysteine peptidases
vaccine
recombinant proteins
antibody response
Online Access:http://vacres.pasteur.ac.ir/article-1-164-en.html

Internet

http://vacres.pasteur.ac.ir/article-1-164-en.html

Similar Items